ORKA Covered Call Strategy
ORKA (Oruka Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
ORKA (Oruka Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $7.15B, a beta of -0.39 versus the broader market, a 52-week range of 25.23-115.52, average daily share volume of 920K, a public-listing history dating back to 1997, approximately 68 full-time employees. These structural characteristics shape how ORKA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.39 indicates ORKA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a covered call on ORKA?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
ORKA snapshot
As of November 13, 2026, spot at $105.67, ATM IV 73.90%, IV rank 13.35%, expected move 21.19%. The covered call on ORKA below is built from the November 13, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this covered call structure on ORKA specifically: ORKA IV at 73.90% is on the cheap side of its 1-year range, which means a premium-selling ORKA covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 21.19% (roughly $22.39 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ORKA expiries trade a higher absolute premium for lower per-day decay. Position sizing on ORKA should anchor to the underlying notional of $105.67 per share and to the trader's directional view on ORKA stock.
ORKA covered call setup
The ORKA covered call below is built from the November 13, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ORKA at $105.67 on that close, the first option leg uses a $110.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ORKA chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ORKA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $105.67 | long |
| Sell 1 | Call | $110.00 | $7.70 |
ORKA covered call risk and reward
- Net Premium / Debit
- -$9,797.00
- Max Profit (per contract)
- $1,203.00
- Max Loss (per contract)
- -$9,796.00
- Breakeven(s)
- $97.97
- Risk / Reward Ratio
- 0.123
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
ORKA covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on ORKA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$9,796.00 |
| $23.37 | -77.9% | -$7,459.69 |
| $46.74 | -55.8% | -$5,123.38 |
| $70.10 | -33.7% | -$2,787.07 |
| $93.46 | -11.6% | -$450.75 |
| $116.83 | +10.6% | +$1,203.00 |
| $140.19 | +32.7% | +$1,203.00 |
| $163.55 | +54.8% | +$1,203.00 |
| $186.91 | +76.9% | +$1,203.00 |
| $210.28 | +99.0% | +$1,203.00 |
When traders use covered call on ORKA
Covered calls on ORKA are an income strategy run on existing ORKA stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
ORKA thesis for this covered call
The market-implied 1-standard-deviation range for ORKA extends from approximately $83.28 on the downside to $128.06 on the upside. A ORKA covered call collects premium on an existing long ORKA position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether ORKA will breach that level within the expiration window. Current ORKA IV rank near 13.35% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ORKA at 73.90%. As a Healthcare name, ORKA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ORKA-specific events.
ORKA covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ORKA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ORKA alongside the broader basket even when ORKA-specific fundamentals are unchanged. Short-premium structures like a covered call on ORKA carry tail risk when realized volatility exceeds the implied move; review historical ORKA earnings reactions and macro stress periods before sizing. Always rebuild the position from current ORKA chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on ORKA?
- A covered call on ORKA is the covered call strategy applied to ORKA (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With ORKA stock at $105.67 on the November 13, 2026 close, the strikes shown on this page are snapped to the nearest listed ORKA chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are ORKA covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the ORKA covered call priced from the November 13, 2026 end-of-day chain at a 30-day expiry (ATM IV 73.90%), the computed maximum profit is $1,203.00 per contract and the computed maximum loss is -$9,796.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ORKA covered call?
- The breakeven for the ORKA covered call priced on this page is roughly $97.97 at expiration, derived from the November 13, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ORKA market-implied 1-standard-deviation expected move in the same options snapshot is approximately 21.19%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on ORKA?
- Covered calls on ORKA are an income strategy run on existing ORKA stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current ORKA implied volatility affect this covered call?
- ORKA ATM IV is at 73.90% with IV rank near 13.35%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.